Conceptual models of drug-drug interactions: A summary of recent efforts

We present a review of drug-drug interactions knowledge representations.We have identified 29 relevant documents describing 15 models or resources.Most of the models were created for natural language processing or DDI inference.To compare the models, we represent them in a common framework using UML diagrams. Conceptual modeling elicits and describes general knowledge in a particular domain and is a fundamental step in the development of knowledge-based systems. However, different conceptual models (CMs) could represent the same domain because they result from human intellectual activity with different objectives. Analyzing previous related efforts is crucial when conceptualizing a domain to avoid duplication, increase interoperability and ensure scientific conformity. Our domain of interest is drug-drug interactions (DDIs), and here we review 15 studies that have attempted total or partial representation of the DDI domain. Direct comparison of these different conceptualizations is complex because CMs are usually not provided, differ considerably from each other or are described with diverse formalisms at different abstraction levels. Therefore, to compare these CMs, we represent all of them in a common representation framework. Here, we compare the scope, content, final implementation and applications of CMs of the DDI domain. We aim to identify which aspects of DDIs have been conceptualized, characterize how this information has been modeled by different research groups, describe how each CM has been translated and illustrate the applications generated from the final models.

[1]  Olivier Bodenreider,et al.  Leveraging MEDLINE indexing for pharmacovigilance - Inherent limitations and mitigation strategies , 2015, J. Biomed. Informatics.

[2]  Amedeo Napoli,et al.  Suggested Ontology for Pharmacogenomics (SO-Pharm): Modular Construction and Preliminary Testing , 2006, OTM Workshops.

[3]  Peter L. Elkin,et al.  Initializing the VA medication reference terminology using UMLS metathesaurus co-occurrences , 2002, AMIA.

[4]  Paloma Martínez,et al.  Turning user generated health-related content into actionable knowledge through text analytics services , 2016, Comput. Ind..

[5]  Jodi Schneider,et al.  Towards a foundational representation of potential drug-drug interaction knowledge. , 2014, CEUR workshop proceedings.

[6]  M. Pirmohamed,et al.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.

[7]  C E Lipscomb,et al.  Medical Subject Headings (MeSH). , 2000, Bulletin of the Medical Library Association.

[8]  Paola Russo,et al.  A system for the extraction and representation of summary of product characteristics content , 2013, Artif. Intell. Medicine.

[9]  M. Ashburner,et al.  The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration , 2007, Nature Biotechnology.

[10]  David S. Wishart,et al.  DrugBank 4.0: shedding new light on drug metabolism , 2013, Nucleic Acids Res..

[11]  Christopher G. Chute,et al.  BioPortal: ontologies and integrated data resources at the click of a mouse , 2009, Nucleic Acids Res..

[12]  Christoph Steinbeck,et al.  Recent Developments in the ChEBI Ontology , 2011, ICBO.

[13]  P. Bork,et al.  A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.

[14]  Kent A. Spackman,et al.  SNOMED clinical terms: overview of the development process and project status , 2001, AMIA.

[15]  Akihiko Konagaya,et al.  Towards an In Silico Approach to Personalized Pharmacokinetics , 2012 .

[16]  Mathias Brochhausen,et al.  Formalizing Knowledge and Evidence about Potential Drug-drug Interactions , 2015, BDM2I@ISWC.

[17]  Pieter de Vries Robbé,et al.  A formal framework of knowledge to support rational psychoactive drug selection , 2001, Artif. Intell. Medicine.

[18]  Paolo Terenziani,et al.  An ontological knowledge and multiple abstraction level decision support system in healthcare , 2014, Decis. Anal..

[19]  Ira J. Kalet,et al.  Modeling Drug Mechanism Knowledge Using Evidence and Truth Maintenance , 2007, IEEE Transactions on Information Technology in Biomedicine.

[20]  Mathias Brochhausen,et al.  Towards a Consistent and Scientifically Accurate Drug Ontology , 2013, ICBO.

[21]  Ira J. Kalet,et al.  Computing with evidence: Part I: A drug-mechanism evidence taxonomy oriented toward confidence assignment , 2009, J. Biomed. Informatics.

[22]  María Herrero Zazo Semantic resources in pharmacovigilance: a corpus and an ontology for drug-drug interactions , 2015 .

[23]  Atif Khan,et al.  Integrating Machine Learning Into a Medical Decision Support System to Address the Problem of Missing Patient Data , 2012, 2012 11th International Conference on Machine Learning and Applications.

[24]  Kazuhiko Ohe,et al.  Development of Description Framework of Pharmacodynamics Ontology and Its Application to Possible Drug-drug Interaction Reasoning , 2013, MedInfo.

[25]  Jingcheng Du,et al.  Extracting drug-enzyme relation from literature as evidence for drug drug interaction , 2016, J. Biomed. Semant..

[26]  Ira J. Kalet,et al.  Computing with evidence: Part II: An evidential approach to predicting metabolic drug-drug interactions , 2009, J. Biomed. Informatics.

[27]  Xiaowei Xu,et al.  Mining FDA drug labels using an unsupervised learning technique - topic modeling , 2011, BMC Bioinformatics.

[28]  John R Horn,et al.  Proposal for a New Tool to Evaluate Drug Interaction Cases , 2007, The Annals of pharmacotherapy.

[29]  María Herrero-Zazo,et al.  Application of Machine Learning in Knowledge Discovery for Pharmaceutical Drug-drug Interactions , 2016, International Workshop on Knowledge Discovery on the Web.

[30]  Antoni Olivé,et al.  Conceptual modeling of information systems , 2007 .

[31]  Michael A. Wittie,et al.  Consensus Recommendations for Systematic Evaluation of Drug–Drug Interaction Evidence for Clinical Decision Support , 2015, Drug Safety.

[32]  Carole A. Goble,et al.  A descriptive semantic formalism for medicine , 1993, Proceedings of IEEE 9th International Conference on Data Engineering.

[33]  Nicole Tourigny,et al.  Bio2RDF: Towards a mashup to build bioinformatics knowledge systems , 2008, J. Biomed. Informatics.

[34]  Hans-Michael Müller,et al.  Textpresso: An Ontology-Based Information Retrieval and Extraction System for Biological Literature , 2004, PLoS biology.

[35]  Ming Yang,et al.  Filtering big data from social media - Building an early warning system for adverse drug reactions , 2015, J. Biomed. Informatics.

[36]  E. Molden,et al.  Severity and Management of Drug–Drug Interactions in Acute Geriatric Patients , 2013, Drugs & Aging.

[37]  Paloma Martínez,et al.  SemEval-2013 Task 9 : Extraction of Drug-Drug Interactions from Biomedical Texts (DDIExtraction 2013) , 2013, *SEMEVAL.

[38]  Olivier Bodenreider,et al.  Evaluating drug-drug interaction information in NDF-RT and DrugBank , 2015, J. Biomed. Semant..

[39]  Cui Tao,et al.  OAE: The Ontology of Adverse Events , 2014, J. Biomed. Semant..

[40]  Luis Tari,et al.  Semantic Inference for Pharmacokinetic Drug-Drug Interactions , 2014, 2014 IEEE International Conference on Semantic Computing.

[41]  Paloma Martínez,et al.  DINTO: Using OWL Ontologies and SWRL Rules to Infer Drug-Drug Interactions and Their Mechanisms , 2015, J. Chem. Inf. Model..

[42]  Judith A. Blake,et al.  Gene Ontology annotations: what they mean and where they come from , 2008, BMC Bioinformatics.

[43]  Xu Han,et al.  An integrated pharmacokinetics ontology and corpus for text mining , 2013, BMC Bioinformatics.

[44]  Paloma Martínez,et al.  Pharmacovigilance through the development of text mining and natural language processing techniques , 2015, J. Biomed. Informatics.

[45]  O Bodenreider,et al.  Biomedical ontologies in action: role in knowledge management, data integration and decision support. , 2008, Yearbook of medical informatics.

[46]  E. Olvey,et al.  Comparison of Critical Drug–Drug Interaction Listings: The Department of Veterans Affairs Medical System and Standard Reference Compendia , 2010, Clinical pharmacology and therapeutics.

[47]  Jeffrey Aronson Communicating information about drug interactions , 2007 .

[48]  Sumi Yoshikawa,et al.  Drug Interaction Ontology (DIO) for Inferences of Possible Drug-drug Interactions , 2004, MedInfo.

[49]  Patrice Degoulet,et al.  Modeling and Acquisition of Drug-Drug Interaction Knowledge , 2007, MedInfo.

[50]  Peter J. F. Lucas,et al.  Foundations of Biomedical Knowledge Representation , 2015, Lecture Notes in Computer Science.

[51]  N. Shah,et al.  Pharmacovigilance Using Clinical Notes , 2013, Clinical pharmacology and therapeutics.

[52]  Asunción Gómez-Pérez,et al.  Selecting and Customizing a Mereology Ontology for its Reuse in a Pharmaceutical Product Ontology , 2008, FOIS.

[53]  Paloma Martínez,et al.  Lessons learnt from the DDIExtraction-2013 Shared Task , 2014, J. Biomed. Informatics.

[54]  Silvana Quaglini,et al.  Summary of Product Characteristics content extraction for a safe drugs usage , 2012, J. Biomed. Informatics.

[55]  Paloma Martínez,et al.  Application of Domain Ontologies to Natural Language Processing: A Case Study for Drug-Drug Interactions , 2015, Int. J. Inf. Retr. Res..

[56]  Maria Liakata,et al.  Dynamic enhancement of drug product labels to support drug safety, efficacy, and effectiveness , 2013, J. Biomed. Semant..

[57]  Ira J. Kalet,et al.  Qualitative Pharmacokinetic Modeling of Drugs , 2005, AMIA.

[58]  W. Paul Nichol,et al.  Research Paper: Practitioners' Views on Computerized Drug-Drug Interaction Alerts in the VA System , 2007, J. Am. Medical Informatics Assoc..

[59]  Stefano Spaccapietra,et al.  Modular Ontologies: Concepts, Theories and Techniques for Knowledge Modularization , 2009, Modular Ontologies.